+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Immune Pharmaceuticals - logo

Immune Pharmaceuticals is a clinical stage biopharmaceutical company that develops novel targeted therapeutics in the immuno-inflammation and immuno-oncology areas. The company's lead product candidate is Bertilimumab, a human monoclonal antibody, which is in Phase II clinical trial for the treatment of ulcerative colitis, bullous pemphigoid, and Crohn's disease. Immune Pharmaceuticals, Inc. was founded in 2010 and is headquartered in New York, New York.

From
Alpha Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
From
Alpha-1 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha-1 Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Loading Indicator